South African scientists have found a way to single out the problematic parts of the bacteria causing TB that results in drug resistance.
Academic rigor, journalistic flair
Articles on Tuberculosis (TB)
Displaying 141 - 160 of 178 articles
African scientists have developed and patented a test for TB that overcomes two major challenges with current methods: it delivers quick results and is much cheaper.
Understanding what causes diseases is a life-and-death matter. It is a complicated issue that has generated a great deal of debate in the medical community.
Many people in the U.S. have no idea that TB is still found here, or what a major health risk it poses in other parts of the world.
In countries such as South Africa with a high burden of TB and HIV, vitamin D could be an extremely effective and cheap weapon to include in the arsenal against TB and HIV.
There is an increasing focus on alternative treatment strategies, developed to treat other diseases and conditions but re-purposed to tackle TB.
For thousands of miners who have developed silicosis from years of work on South Africa’s gold mines, a landmark court case will change their lives.
As much as animals may pass on viruses to humans, humans pass on viruses which are sometimes lethal to the animal world as well.
Health has secured its place as one of the 17 Sustainable Development Goals. But without clear mechanisms to report, finance or engage other sectors, could more end up as less?
We used to think that antibiotic resistance came at a cost for bacteria, making them weaker. It turns out that for some bacteria, resistance can make them stronger and more virulent.
Although one third of the world’s population have the TB bacterium, the disease only develops in 10%, which may be linked to genetic factors.
More than 1.5 million people die of tuberculosis across the world every year. Although testing and screening has improved and more drugs are available, it is not enough to conquer the scourge.
People living in close proximity to animals infected with Bovine TB are at a risk of contracting the disease through drinking their milk and eating their meat.
Though no magic bullet, bedaquiline has provided rich lessons about the challenges posed in global efforts to curb the TB epidemic.
Some experts worry that the Ebola crisis is diverting attention and resources away from neglected diseases with a substantially larger disease incidence.
Nations of the world came together in 2000 to make a solemn commitment to humanity to combat tuberculosis (TB), HIV/AIDS and other devastating diseases. This pushed governments to set up aggressive public…
The number of children developing tuberculosis (TB) worldwide is likely to be far higher than initial World Health Organization…
Bovine tuberculosis is a major problem in the UK: in 2013 around 8m cattle were tested and 32,000 slaughtered at a cost of an estimated £100m, including compensation – a huge economic burden that makes…
For many people in the UK, tuberculosis is a disease that’s been out of sight, out of mind for a number of years. Although it is low and middle-income countries that bear the burden of TB-related sickness…
Tuberculosis, or consumption as it used to be known, sounds like a disease that we’ve managed to fight off for good. But a drug-resistant strain of the bacteria that causes it is making a comeback, and…
Top contributors
-
Canada Research Chair of Epidemiology & Global Health, McGill University
-
Assistant Professor, Africa Health Research Institute (AHRI)
-
Associate Professor, Melbourne Health
-
Faculty Member, Africa Health Research Institute; Associate professor, UCL
-
Head of the Centre of Excellence for Biomedical TB Research, University of the Witwatersrand
-
Extraordinary Senior Lecture in the Department of Global Health, Stellenbosch University
-
Honorary Research Associate, Centre for Infectious Disease Epidemiology and Research, University of Cape Town
-
Associate Professor in Paediatrics and Child Health, University of Sydney
-
Associate Professor, Pharmaceutical Sciences, University of the Western Cape
-
Infectious Diseases Physician and Senior Clinical Lecturer, Liverpool School of Tropical Medicine and Honorary Research Associate, University of Liverpool
-
Faculty Member, Africa Health Research Institute; Wellcome Trust Senior Research Fellow, UCL
-
Associate Professor of Biomedical Engineering, University of Michigan
-
Head of the Division of Pulmonology, University of Cape Town
-
Associate Professor, SARChI Research Chair in Mycobactomics, Stellenbosch University
-
Head of the Immunology Research Group at the Division of Molecular Biology & Human Genetics, Department of Biomedical Sciences, Faculty of Medicine & Health Sciences, Stellenbosch University
